Bisostad 5 Stella medicine for hypertension and angina (3 blisters x 10 tablets)
Dosage form Box of 3 blisters x 10 tablets
Specifications Bisoprolol
Ingredient High blood pressure, angina
Ingredient
| Composition information | Content |
| Bisoprolol | 5mg |
Uses
indications
Bisostad 5 drugs are indicated in the case:
Bisoprolol is used in the form of fumarat in controlling hypertension and angina. The drug is also used to combine standard therapy in patients with chronic heart failure.
Pharmacokology
Pharmacological group: selective beta blockers.
Bisoprolol is a selective blockbuster Beta 1 - Adrenergic but has no membrane stability and has no effect similar to intrinsic sympathetic nerve when used within the dose of treatment.
In low doses, Bisoprolol inhibits selectively responding to adrenergic stimulation by competing for the Beta 1 - adrenergic receptor of the heart, while less acting on the beta 2 adrenergic receptor of bronchial muscles and vascular walls. With high doses, the selective properties of bisoprolol on the beta 1 receptor - Adrenergic usually drops and the drug will compete inhibiting both beta 1 and beta 2 -adrenergic receptors.
Pharmacokinetics
absorption
Bisoprolol is absorbed almost completely through the gastrointestinal tract and oral bioavailability is about 90% because the drug is less metabolized through the liver for the first time. Peak concentration in plasma is achieved from 2-4 hours after drinking.
Distribution
about 30% bisoprolol binds to plasma proteins. Bisoprolol is a moderate solute in lipid.
Metabolism and elimination
The drug is metabolized in the liver and is eliminated in the urine, about 50% of the drug in the form of intact and 50% in the form of metabolites. The drug has a semi -discharged time in plasma about 10 - 12 hours.
Before taking Bisostad 5 Stella medicine for hypertension and angina (3 blisters x 10 tablets)
How to use
Bisostad 5 is taken orally.
Dosage
Hypertension or angina
The usual oral dose of Bisoprolol Fumarat is 5 - 10 mg x 1 time/day, the maximum dose is recommended for 20 mg/day.
Sound heart failure
The starting dose of Bisoprolol Fumarat is 1.25 mg x 1 time/day. If tolerated, the dose can be doubled after 1 week and then increasing the dose slowly for about 14 weeks to the maximum dose is tolerated, should not exceed 10 mg x 1 time/day.
Dosage for patients with liver failure and kidney failure
Bisoprolol Fumarat's starting dose for patients with hypertension 2.5 mg/day and increased the dose slowly above patients with severe hepatic impairment or renal failure (creatinine clearine Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?
Symptoms
Slow heart rate, hypotension, congestive heart failure, trachea and hypoglycemia are the most common signs of beta blockers overdose.
Handling
Normally, if overdose occurs, Bisoprolol stops and conducts supportive treatment and symptomatic treatment. There are a few data that suggest bisoprolol fumarat is not separated. Based on pharmacokinetics and recommendations for other beta blockers, consider general methods after seeing clinical signs:
Side Effects
When using Bisostad 5, you may experience unwanted effects (ADR).
Instructions on how to handle ADR
When ADR occurs with the above manifestations, it can be treated as cases of overdose symptoms (see overdose and treatment).
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Bisostad 5 contraindications in the following cases:
Acute heart failure or during loss of loss of heart failure requires muscle -oriented therapy.
Cardioma.
Atrial atrial clog II or III (no pacemaker).
Sinus syndrome.
Atrial sinus block.
Slow heart rate below 60 times/minute before starting treatment.
Hypotension (systolic pressure below 100 mmHg).
Severe bronchial asthma or chronic obstructive pulmonary disease.
The final stage of peripheral congestion and Raynaud syndrome.
Chromium -loving cells are not treated.
Metabolic acidosis.
Hypersensitivity to bisoprolol or any ingredients of the drug.
Be cautious when using
need to adjust the dose of bisoprolol carefully for patients with liver or kidney failure.
heart failure
Psychic stimulation is an essential component that supports circulatory function in the beginning of congestive heart failure and beta blockers can lead to further decline in cardiac contraction and promote worse heart failure.
Patients without a history of heart failure
The continuous inhibition of the heart muscle of beta blockers on some patients can cause heart failure. When there are signs and the first symptoms of heart failure, it is necessary to consider stopping the drug. In some cases, Beta blockers can continue to continue treating heart failure with other drugs.
Sudden stop treatment
Server angina and in some cases of myocardial infarction or ventricular arrhythmia in people with coronary artery disease after sudden stopping of beta blockers.
Peripheral vascular disease
Beta blockers can cause or worsen artery anemia in patients with peripheral vascular disease.
Bronchospasm
In general, patients with bronchospasm must not use beta blockers. However, due to the relatively selective properties Beta 1, caution can be used with bisoprolol in patients with bronchospasmic spasms that do not respond or unable to tolerate other anti -hypertension treatment. Because the beta 1 selection is not absolutely absolutely, the lowest bisoprolol dose is possible, and starts at a dose of 2.5 mg. There must be a Beta 2 -maneuverbate (bronchodilator).
diabetes and hypoglycemia
Beta blockers can cover the manifestations of hypoglycemia, especially tachycardia. Unstolant beta blockers may increase the level of hypoglycemia caused by insulin and slow down the recovery of serum glucose concentrations. Due to the selective properties of beta 1, this is less likely to occur with bisoprolol. However, it is necessary to warn patients or hypoglycemia, or people with diabetes using insulin or oral hypoglycemic medications for their ability and must use bisoprolol.
Thyroid hyperplation disease
Beta blockers cover the clinical signs of hyperthyroidism such as fast heartbeat.
The ability to drive and operate machinery
bisoprolol can cause unwanted effects such as drowsiness, dizziness and fatigue, which can affect the ability to drive or operate the patient's machines.
Pregnancy
There is no full and tight test in pregnant women. Bisoprolol is only used during pregnancy when proving the benefit of treatment than the potential risk to the fetus.
Breastfeeding period
Small amount of Bisoprolol was discovered in mother mouse milk. It is unknown whether or not to excrete in human milk or not. Because many drugs are excreted on breast milk, they should be cautious when using bisoprolol for women who are breastfeeding.
Medicinal interaction
Patients who are taking drugs that exhausted catecholamine such as reserpin or guanethidin, should be closely monitored because of the impact of the inhibition of beta - adrenergic can reduce the excessive sympathetic activity. In patients being treated simultaneously with clonidin, if stopped treatment, bisoprolol should be discontinued a few days before stopping clonidin.
Be cautious when using Bisoprolol simultaneously with cardiac inhibitors or atrial inhibitors, such as calcium blockers [specifically like phenylalkylamin (verapamil) and benzothiazepine (diltiazem)] or arrhythmias such as disopyramid.
Concentrated with rifampicin increases the metabolism of bisoprolol, resulting in shortening the waste time of bisoprolol. However, it is not necessary to adjust the first dose.
Risk of anaphylaxis: During the use of beta blockers, patients with a history of anaphylactic reaction with different allergens may react stronger with the use of repeated drugs, by accident, diagnosis or treatment. Such patients may not respond to conventional doses of epinephrin used to treat allergic reactions.
Storage
In closed packaging, in a dry place, avoiding light, temperatures below 30 ° C.
Expiry date: 24 months from the date of manufacture. Do not use overdue drugs stated on the packaging.
Other drugs
- AVOMINE 25MG TABLETS
- BLOPRESS TABLETS 8MG
- BETAHISTINE 24 MG TABLETS
- CO-AMOXICLAV 400/57 MG/5 ML POWDER FOR ORAL SUSPENSION
- NEUROTONE
- PANADOL ADVANCE 500 MG TABLETS
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions